Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
The worldwide prevalence of obesity more than doubled between 1990 and 2022
They can also monitor for side effects and adjust your treatment if needed
SSBP1 drives high fructose-induced glomerular podocyte ferroptosis via activating DNA-PK/p53 pathway
Ji L, Gao L, Xue H, et al
Retrograde tracing studies The abdomen of mice (n = 3) was exposed after a midline laparotomy